JP2008510006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008510006A5 JP2008510006A5 JP2007527895A JP2007527895A JP2008510006A5 JP 2008510006 A5 JP2008510006 A5 JP 2008510006A5 JP 2007527895 A JP2007527895 A JP 2007527895A JP 2007527895 A JP2007527895 A JP 2007527895A JP 2008510006 A5 JP2008510006 A5 JP 2008510006A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- tetrahydro
- benzimidazol
- piperazinyl
- quinolinamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 62
- 125000000753 cycloalkyl group Chemical group 0.000 claims 62
- 125000003342 alkenyl group Chemical group 0.000 claims 48
- 125000000304 alkynyl group Chemical group 0.000 claims 48
- -1 5,6,7,8-tetrahydro-8-quinolinyl Chemical group 0.000 claims 32
- 150000001875 compounds Chemical class 0.000 claims 31
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 28
- 125000001188 haloalkyl group Chemical group 0.000 claims 27
- 150000001412 amines Chemical class 0.000 claims 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 17
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 claims 14
- 150000001540 azides Chemical class 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 14
- 150000002367 halogens Chemical class 0.000 claims 14
- 125000004450 alkenylene group Chemical group 0.000 claims 7
- 150000003973 alkyl amines Chemical group 0.000 claims 7
- 125000002947 alkylene group Chemical group 0.000 claims 7
- 125000004419 alkynylene group Chemical group 0.000 claims 7
- 125000005724 cycloalkenylene group Chemical group 0.000 claims 7
- 125000002993 cycloalkylene group Chemical group 0.000 claims 7
- 101150008896 hetR gene Proteins 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 125000000623 heterocyclic group Chemical group 0.000 claims 7
- 125000003107 substituted aryl group Chemical group 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 4
- 238000006268 reductive amination reaction Methods 0.000 claims 4
- JKAGHWHIEIKQQE-HXUWFJFHSA-N (8r)-n-methyl-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CN([C@H]1C2=NC=CC=C2CCC1)CC(N(C1=2)C)=NC1=CC=CC=2N1CCN(C)CC1 JKAGHWHIEIKQQE-HXUWFJFHSA-N 0.000 claims 3
- JEHABMXQHSEKPF-NRFANRHFSA-N (8s)-n-[[1-ethyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-n-methyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C=12N(CC)C(CN(C)[C@@H]3C4=NC=CC=C4CCC3)=NC2=CC=CC=1N1CCN(C)CC1 JEHABMXQHSEKPF-NRFANRHFSA-N 0.000 claims 3
- GJJZPHWMEXPWCE-MHZLTWQESA-N (8s)-n-benzyl-n-[[1-ethyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound N=1C2=CC=CC(N3CCN(C)CC3)=C2N(CC)C=1CN([C@@H]1C2=NC=CC=C2CCC1)CC1=CC=CC=C1 GJJZPHWMEXPWCE-MHZLTWQESA-N 0.000 claims 3
- WMXSCDKRBQLQHT-QFIPXVFZSA-N (8s)-n-ethyl-n-[[1-ethyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CCN([C@@H]1C2=NC=CC=C2CCC1)CC(N(C1=2)CC)=NC1=CC=CC=2N1CCN(C)CC1 WMXSCDKRBQLQHT-QFIPXVFZSA-N 0.000 claims 3
- UQUSGFGEARIPEG-IBGZPJMESA-N (8s)-n-methyl-n-[(1-methyl-7-piperazin-1-ylbenzimidazol-2-yl)methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CN([C@@H]1C2=NC=CC=C2CCC1)CC(N(C1=2)C)=NC1=CC=CC=2N1CCNCC1 UQUSGFGEARIPEG-IBGZPJMESA-N 0.000 claims 3
- JKAGHWHIEIKQQE-FQEVSTJZSA-N (8s)-n-methyl-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CN([C@@H]1C2=NC=CC=C2CCC1)CC(N(C1=2)C)=NC1=CC=CC=2N1CCN(C)CC1 JKAGHWHIEIKQQE-FQEVSTJZSA-N 0.000 claims 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N 1-propanol Substances CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- UOGDWUJAQURVRZ-UHFFFAOYSA-N n-(cyclopropylmethyl)-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N(C)C(CN(CC1CC1)C1C3=NC=CC=C3CCC1)=N2 UOGDWUJAQURVRZ-UHFFFAOYSA-N 0.000 claims 3
- PHRYNVIBEQXSSX-UHFFFAOYSA-N n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-n-propyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(CCC)CC(N(C1=2)C)=NC1=CC=CC=2N1CCN(C)CC1 PHRYNVIBEQXSSX-UHFFFAOYSA-N 0.000 claims 3
- WOUDZZACVGCCAB-UHFFFAOYSA-N n-ethyl-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(CC)CC(N(C1=2)C)=NC1=CC=CC=2N1CCN(C)CC1 WOUDZZACVGCCAB-UHFFFAOYSA-N 0.000 claims 3
- JKAGHWHIEIKQQE-UHFFFAOYSA-N n-methyl-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(N(C1=2)C)=NC1=CC=CC=2N1CCN(C)CC1 JKAGHWHIEIKQQE-UHFFFAOYSA-N 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- FTIUDAIKGCFJLJ-UHFFFAOYSA-N (3-aminopyrrolidin-1-yl)-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]methanone Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)N1CCC(N)C1 FTIUDAIKGCFJLJ-UHFFFAOYSA-N 0.000 claims 2
- NACDDZQXTMQNSA-UHFFFAOYSA-N (4-aminopiperidin-1-yl)-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]methanone Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)N1CCC(N)CC1 NACDDZQXTMQNSA-UHFFFAOYSA-N 0.000 claims 2
- RARYKEKXHDOFGV-LJQANCHMSA-N (8r)-n-methyl-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CN([C@H]1C2=NC=CC=C2CCC1)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 RARYKEKXHDOFGV-LJQANCHMSA-N 0.000 claims 2
- TYTCWJIKJIONKI-QFIPXVFZSA-N (8s)-n-(cyclopropylmethyl)-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(CN(CC1CC1)[C@@H]1C3=NC=CC=C3CCC1)N2 TYTCWJIKJIONKI-QFIPXVFZSA-N 0.000 claims 2
- XILRUNRCEGYBHT-QFIPXVFZSA-N (8s)-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-n-propan-2-yl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CC(C)N([C@@H]1C2=NC=CC=C2CCC1)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 XILRUNRCEGYBHT-QFIPXVFZSA-N 0.000 claims 2
- YCEZDFREVJWARV-NRFANRHFSA-N (8s)-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-n-propyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CCCN([C@@H]1C2=NC=CC=C2CCC1)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 YCEZDFREVJWARV-NRFANRHFSA-N 0.000 claims 2
- WOUHFSTYAZRQGY-IRLDBZIGSA-N (8s)-n-[[4-[(8ar)-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl]-1h-benzimidazol-2-yl]methyl]-n-ethyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2[C@H]1N(CC)CC1=NC2=C(N3C[C@H]4CCCN4CC3)C=CC=C2N1 WOUHFSTYAZRQGY-IRLDBZIGSA-N 0.000 claims 2
- VUJPYVQEUCGIRD-CTNGQTDRSA-N (8s)-n-[[4-[(8ar)-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl]-1h-benzimidazol-2-yl]methyl]-n-methyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2[C@H]1N(C)CC1=NC2=C(N3C[C@H]4CCCN4CC3)C=CC=C2N1 VUJPYVQEUCGIRD-CTNGQTDRSA-N 0.000 claims 2
- KAXGLACAYVKTCC-GGAORHGYSA-N (8s)-n-[[4-[(8ar)-3,4,6,7,8,8a-hexahydro-1h-pyrrolo[1,2-a]pyrazin-2-yl]-1h-benzimidazol-2-yl]methyl]-n-propyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2[C@H]1N(CCC)CC1=NC2=C(N3C[C@H]4CCCN4CC3)C=CC=C2N1 KAXGLACAYVKTCC-GGAORHGYSA-N 0.000 claims 2
- HINBAFPNGJXEIX-SANMLTNESA-N (8s)-n-benzyl-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N(C)C(CN(CC=1C=CC=CC=1)[C@@H]1C3=NC=CC=C3CCC1)=N2 HINBAFPNGJXEIX-SANMLTNESA-N 0.000 claims 2
- FFKHNWAOHAYKCR-VWLOTQADSA-N (8s)-n-benzyl-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(CN(CC=1C=CC=CC=1)[C@@H]1C3=NC=CC=C3CCC1)N2 FFKHNWAOHAYKCR-VWLOTQADSA-N 0.000 claims 2
- WOUDZZACVGCCAB-NRFANRHFSA-N (8s)-n-ethyl-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CCN([C@@H]1C2=NC=CC=C2CCC1)CC(N(C1=2)C)=NC1=CC=CC=2N1CCN(C)CC1 WOUDZZACVGCCAB-NRFANRHFSA-N 0.000 claims 2
- VQKSJFFHUQOXEV-FQEVSTJZSA-N (8s)-n-ethyl-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CCN([C@@H]1C2=NC=CC=C2CCC1)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 VQKSJFFHUQOXEV-FQEVSTJZSA-N 0.000 claims 2
- RARYKEKXHDOFGV-IBGZPJMESA-N (8s)-n-methyl-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CN([C@@H]1C2=NC=CC=C2CCC1)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 RARYKEKXHDOFGV-IBGZPJMESA-N 0.000 claims 2
- QQXCIIQQEYYVIU-FQEVSTJZSA-N 2-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl-[(8s)-5,6,7,8-tetrahydroquinolin-8-yl]amino]ethanol Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(CN(CCO)[C@@H]1C3=NC=CC=C3CCC1)N2 QQXCIIQQEYYVIU-FQEVSTJZSA-N 0.000 claims 2
- BKLAKQKYHQAMPO-NRFANRHFSA-N 3-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl-[(8s)-5,6,7,8-tetrahydroquinolin-8-yl]amino]propan-1-ol Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(CN(CCCO)[C@@H]1C3=NC=CC=C3CCC1)N2 BKLAKQKYHQAMPO-NRFANRHFSA-N 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- RSCQVCDQCNRTNS-UHFFFAOYSA-N n-[2-(1h-imidazol-5-yl)ethyl]-1-methyl-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(N(C1=CC=C2)C)=NC1=C2C(=O)NCCC1=CNC=N1 RSCQVCDQCNRTNS-UHFFFAOYSA-N 0.000 claims 2
- KEQUDHCKFFYHDG-UHFFFAOYSA-N (2-methylpiperazin-1-yl)-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]methanone Chemical compound CC1CNCCN1C(=O)C1=CC=CC2=C1N=C(CN(C)C1C3=NC=CC=C3CCC1)N2 KEQUDHCKFFYHDG-UHFFFAOYSA-N 0.000 claims 1
- SEIGKYUPWXPYOF-UHFFFAOYSA-N (4-methyl-1,4-diazepan-1-yl)-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]methanone Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)N1CCCN(C)CC1 SEIGKYUPWXPYOF-UHFFFAOYSA-N 0.000 claims 1
- TYTCWJIKJIONKI-JOCHJYFZSA-N (8r)-n-(cyclopropylmethyl)-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(CN(CC1CC1)[C@H]1C3=NC=CC=C3CCC1)N2 TYTCWJIKJIONKI-JOCHJYFZSA-N 0.000 claims 1
- YCEZDFREVJWARV-OAQYLSRUSA-N (8r)-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-n-propyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CCCN([C@H]1C2=NC=CC=C2CCC1)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 YCEZDFREVJWARV-OAQYLSRUSA-N 0.000 claims 1
- VQKSJFFHUQOXEV-HXUWFJFHSA-N (8r)-n-ethyl-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CCN([C@H]1C2=NC=CC=C2CCC1)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 VQKSJFFHUQOXEV-HXUWFJFHSA-N 0.000 claims 1
- GFKAWKPZHDXHQF-DWACAAAGSA-N (8s)-n-[(1s)-1-(4-methoxyphenyl)ethyl]-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1=CC(OC)=CC=C1[C@H](C)N([C@@H]1C2=NC=CC=C2CCC1)CC1=NC2=C(N3CCN(C)CC3)C=CC=C2N1 GFKAWKPZHDXHQF-DWACAAAGSA-N 0.000 claims 1
- PHRYNVIBEQXSSX-QFIPXVFZSA-N (8s)-n-[[1-methyl-7-(4-methylpiperazin-1-yl)benzimidazol-2-yl]methyl]-n-propyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound CCCN([C@@H]1C2=NC=CC=C2CCC1)CC(N(C1=2)C)=NC1=CC=CC=2N1CCN(C)CC1 PHRYNVIBEQXSSX-QFIPXVFZSA-N 0.000 claims 1
- SPAZYPFSZCWRHW-MHZLTWQESA-N (8s)-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-n-(2-phenylmethoxyethyl)-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(CN(CCOCC=1C=CC=CC=1)[C@@H]1C3=NC=CC=C3CCC1)N2 SPAZYPFSZCWRHW-MHZLTWQESA-N 0.000 claims 1
- AOSZKCJHOXNRRQ-KNKQGSTJSA-N (8s)-n-methyl-n-[[4-[(1r,5r)-7-methyl-3,7-diazabicyclo[3.3.1]nonan-3-yl]-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2[C@H]1N(C)CC(N1)=NC2=C1C=CC=C2N1C[C@]([H])(C2)CN(C)C[C@]2([H])C1 AOSZKCJHOXNRRQ-KNKQGSTJSA-N 0.000 claims 1
- PLCPGWAKLYOXGH-UHFFFAOYSA-N 1,4-diazepan-1-yl-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]methanone Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)N1CCCNCC1 PLCPGWAKLYOXGH-UHFFFAOYSA-N 0.000 claims 1
- TUTCEJURRXOTCW-FQEVSTJZSA-N 2-[(1-methyl-7-piperazin-1-ylbenzimidazol-2-yl)methyl-[(8s)-5,6,7,8-tetrahydroquinolin-8-yl]amino]ethanol Chemical compound C=12N(C)C(CN(CCO)[C@@H]3C4=NC=CC=C4CCC3)=NC2=CC=CC=1N1CCNCC1 TUTCEJURRXOTCW-FQEVSTJZSA-N 0.000 claims 1
- ZYJDJJZRBPKYHA-UHFFFAOYSA-N 2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-3h-benzimidazole-5-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC1=NC2=CC(C(N)=O)=CC=C2N1 ZYJDJJZRBPKYHA-UHFFFAOYSA-N 0.000 claims 1
- ZFLVYJNHMZFULK-UHFFFAOYSA-N 2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-n-(2-piperidin-1-ylpropyl)-1h-benzimidazole-4-carboxamide Chemical compound C=1C=CC=2NC(CN(C)C3C4=NC=CC=C4CCC3)=NC=2C=1C(=O)NCC(C)N1CCCCC1 ZFLVYJNHMZFULK-UHFFFAOYSA-N 0.000 claims 1
- KZZCKGOROMDOGS-UHFFFAOYSA-N 2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-n-(3-morpholin-4-ylpropyl)-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)NCCCN1CCOCC1 KZZCKGOROMDOGS-UHFFFAOYSA-N 0.000 claims 1
- PPCWMUFFNFNOTO-UHFFFAOYSA-N 2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-n-(3-pyrrolidin-1-ylpropyl)-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)NCCCN1CCCC1 PPCWMUFFNFNOTO-UHFFFAOYSA-N 0.000 claims 1
- BXRGVNBGSSKVQV-UHFFFAOYSA-N 2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-n-pyrrolidin-3-yl-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)NC1CCNC1 BXRGVNBGSSKVQV-UHFFFAOYSA-N 0.000 claims 1
- LKKJUYYLZICHDK-UHFFFAOYSA-N 2-amino-1-[4-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]piperazin-1-yl]ethanone Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2N1CCN(C(=O)CN)CC1 LKKJUYYLZICHDK-UHFFFAOYSA-N 0.000 claims 1
- FRZVZLBUYAQLLQ-NRFANRHFSA-N 3-[(1-methyl-7-piperazin-1-ylbenzimidazol-2-yl)methyl-[(8s)-5,6,7,8-tetrahydroquinolin-8-yl]amino]propan-1-ol Chemical compound C=12N(C)C(CN(CCCO)[C@@H]3C4=NC=CC=C4CCC3)=NC2=CC=CC=1N1CCNCC1 FRZVZLBUYAQLLQ-NRFANRHFSA-N 0.000 claims 1
- AYUHGILYDIWLTB-NBJLRHFZSA-N [(1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]methanone Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(N1)=NC2=C1C=CC=C2C(=O)N1C[C@@]2([H])NC[C@]1([H])C2 AYUHGILYDIWLTB-NBJLRHFZSA-N 0.000 claims 1
- UZYUJPSWCDMVEI-UHFFFAOYSA-N [2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]-piperazin-1-ylmethanone Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)N1CCNCC1 UZYUJPSWCDMVEI-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- ITWVSYDHQQETDY-UHFFFAOYSA-N n,n,n'-trimethyl-n'-[2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazol-4-yl]ethane-1,2-diamine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(N1)=NC2=C1C=CC=C2N(C)CCN(C)C ITWVSYDHQQETDY-UHFFFAOYSA-N 0.000 claims 1
- DWASOSKRUBULNA-UHFFFAOYSA-N n-(2-aminoethyl)-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC1=NC2=C(C(=O)NCCN)C=CC=C2N1 DWASOSKRUBULNA-UHFFFAOYSA-N 0.000 claims 1
- CQQDKTZHTMVCMI-UHFFFAOYSA-N n-(3-imidazol-1-ylpropyl)-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)NCCCN1C=CN=C1 CQQDKTZHTMVCMI-UHFFFAOYSA-N 0.000 claims 1
- CXNVDVURPCDBBQ-UHFFFAOYSA-N n-[2-(1-methylimidazol-4-yl)ethyl]-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)NCCC1=CN(C)C=N1 CXNVDVURPCDBBQ-UHFFFAOYSA-N 0.000 claims 1
- VLMHVPDHRBQBED-UHFFFAOYSA-N n-[2-(1h-imidazol-5-yl)ethyl]-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)NCCC1=CNC=N1 VLMHVPDHRBQBED-UHFFFAOYSA-N 0.000 claims 1
- DPKLWXGZKISPJR-UHFFFAOYSA-N n-[2-(1h-imidazol-5-yl)ethyl]-n-methyl-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2C(=O)N(C)CCC1=CNC=N1 DPKLWXGZKISPJR-UHFFFAOYSA-N 0.000 claims 1
- CFNWGVHJUZTQAE-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-3h-benzimidazole-5-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC1=NC2=CC(C(=O)NCCN(C)C)=CC=C2N1 CFNWGVHJUZTQAE-UHFFFAOYSA-N 0.000 claims 1
- NIPDTHOZOIZMEB-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-n-methyl-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-3h-benzimidazole-5-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC1=NC2=CC(C(=O)N(C)CCN(C)C)=CC=C2N1 NIPDTHOZOIZMEB-UHFFFAOYSA-N 0.000 claims 1
- AZGPTXXUFQWOAI-UHFFFAOYSA-N n-[2-(methylamino)ethyl]-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-3h-benzimidazole-5-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC1=NC2=CC(C(=O)NCCNC)=CC=C2N1 AZGPTXXUFQWOAI-UHFFFAOYSA-N 0.000 claims 1
- RNQICXXTWHOGDV-UHFFFAOYSA-N n-[2-[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]propan-2-yl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(C(C)(C)NC1C3=NC=CC=C3CCC1)N2 RNQICXXTWHOGDV-UHFFFAOYSA-N 0.000 claims 1
- PQLNCSVIBGNJKT-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-1h-benzimidazole-4-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(N1)=NC2=C1C=CC=C2C(=O)NCCCN(C)C PQLNCSVIBGNJKT-UHFFFAOYSA-N 0.000 claims 1
- PCHFSEFNDXTJDN-UHFFFAOYSA-N n-[[4-(3-aminopropyl)-1h-benzimidazol-2-yl]methyl]-n-methyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC1=NC2=C(CCCN)C=CC=C2N1 PCHFSEFNDXTJDN-UHFFFAOYSA-N 0.000 claims 1
- AUJRGNBGQHHJBI-UHFFFAOYSA-N n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-9-amine Chemical compound C1CN(C)CCN1C1=CC=CC2=C1N=C(CNC1C3=NC=CC=C3CCCC1)N2 AUJRGNBGQHHJBI-UHFFFAOYSA-N 0.000 claims 1
- TXSSWGGJUUVKKX-UHFFFAOYSA-N n-[[4-[3-(dimethylamino)propyl]-1h-benzimidazol-2-yl]methyl]-n-methyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(N1)=NC2=C1C=CC=C2CCCN(C)C TXSSWGGJUUVKKX-UHFFFAOYSA-N 0.000 claims 1
- FWOUHVFETOOCEE-UHFFFAOYSA-N n-[[4-[[2-(1h-imidazol-5-yl)ethylamino]methyl]-1h-benzimidazol-2-yl]methyl]-n-methyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2CNCCC1=CNC=N1 FWOUHVFETOOCEE-UHFFFAOYSA-N 0.000 claims 1
- MNOSDBUSRSZMAH-UHFFFAOYSA-N n-[[4-chloro-7-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-n-methyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=2)=NC1=C(Cl)C=CC=2N1CCN(C)CC1 MNOSDBUSRSZMAH-UHFFFAOYSA-N 0.000 claims 1
- JXVIGRBEAZIWFL-UHFFFAOYSA-N n-[[5-chloro-4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-n-methyl-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2Cl)=NC1=C2N1CCN(C)CC1 JXVIGRBEAZIWFL-UHFFFAOYSA-N 0.000 claims 1
- PEEKKEHJKFLYMX-RXBHZZDJSA-N n-methyl-n-[(1r)-1-[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-2-phenylmethoxyethyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C([C@H](N(C)C1C2=NC=CC=C2CCC1)C=1NC2=CC=CC(=C2N=1)N1CCN(C)CC1)OCC1=CC=CC=C1 PEEKKEHJKFLYMX-RXBHZZDJSA-N 0.000 claims 1
- SCLHDSJQXSNULJ-DIAVIDTQSA-N n-methyl-n-[(1r)-1-[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]ethyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1=CC=C2NC([C@H](N(C)C3C4=NC=CC=C4CCC3)C)=NC2=C1N1CCN(C)CC1 SCLHDSJQXSNULJ-DIAVIDTQSA-N 0.000 claims 1
- PEEKKEHJKFLYMX-SVNIRARHSA-N n-methyl-n-[(1s)-1-[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-2-phenylmethoxyethyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C([C@@H](N(C)C1C2=NC=CC=C2CCC1)C=1NC2=CC=CC(=C2N=1)N1CCN(C)CC1)OCC1=CC=CC=C1 PEEKKEHJKFLYMX-SVNIRARHSA-N 0.000 claims 1
- AIVVNDNIWAQWOH-UHFFFAOYSA-N n-methyl-n-[(4-piperazin-1-yl-1h-benzimidazol-2-yl)methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2N1CCNCC1 AIVVNDNIWAQWOH-UHFFFAOYSA-N 0.000 claims 1
- KKMUCSXJJSSXRO-UHFFFAOYSA-N n-methyl-n-[2-(methylamino)ethyl]-2-[[methyl(5,6,7,8-tetrahydroquinolin-8-yl)amino]methyl]-3h-benzimidazole-5-carboxamide Chemical compound C1CCC2=CC=CN=C2C1N(C)CC1=NC2=CC(C(=O)N(C)CCNC)=CC=C2N1 KKMUCSXJJSSXRO-UHFFFAOYSA-N 0.000 claims 1
- ADLDLGPOAXVPAX-UHFFFAOYSA-N n-methyl-n-[2-[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]propan-2-yl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)C(C)(C)C(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 ADLDLGPOAXVPAX-UHFFFAOYSA-N 0.000 claims 1
- MKNFQYOGYHJLFR-UHFFFAOYSA-N n-methyl-n-[[4-(3-piperidin-1-ylpropyl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2CCCN1CCCCC1 MKNFQYOGYHJLFR-UHFFFAOYSA-N 0.000 claims 1
- JFCUMHNRFWTSSD-UHFFFAOYSA-N n-methyl-n-[[4-(3-pyrrolidin-1-ylpropyl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2CCCN1CCCC1 JFCUMHNRFWTSSD-UHFFFAOYSA-N 0.000 claims 1
- RARYKEKXHDOFGV-UHFFFAOYSA-N n-methyl-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 RARYKEKXHDOFGV-UHFFFAOYSA-N 0.000 claims 1
- PLEVUJATIJXXQN-UHFFFAOYSA-N n-methyl-n-[[4-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-6,7-dihydro-5h-cyclopenta[b]pyridin-7-amine Chemical compound C1CC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2N1CCN(C)CC1 PLEVUJATIJXXQN-UHFFFAOYSA-N 0.000 claims 1
- HOTFDACOUFWRFX-UHFFFAOYSA-N n-methyl-n-[[4-(piperazin-1-ylmethyl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C)CC(NC1=CC=C2)=NC1=C2CN1CCNCC1 HOTFDACOUFWRFX-UHFFFAOYSA-N 0.000 claims 1
- AOYUFWJGGKRAOW-UHFFFAOYSA-N n-propan-2-yl-n-[[4-(4-propan-2-ylpiperazin-1-yl)-1h-benzimidazol-2-yl]methyl]-5,6,7,8-tetrahydroquinolin-8-amine Chemical compound C1CCC2=CC=CN=C2C1N(C(C)C)CC(NC1=CC=C2)=NC1=C2N1CCN(C(C)C)CC1 AOYUFWJGGKRAOW-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60192804P | 2004-08-16 | 2004-08-16 | |
| PCT/US2005/028811 WO2006023400A2 (en) | 2004-08-16 | 2005-08-12 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008510006A JP2008510006A (ja) | 2008-04-03 |
| JP2008510006A5 true JP2008510006A5 (https=) | 2008-10-02 |
Family
ID=35968075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007527895A Pending JP2008510006A (ja) | 2004-08-16 | 2005-08-12 | 化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20080045537A1 (https=) |
| EP (1) | EP1789045A2 (https=) |
| JP (1) | JP2008510006A (https=) |
| KR (1) | KR20070042568A (https=) |
| CN (1) | CN101039672A (https=) |
| AR (1) | AR050522A1 (https=) |
| AU (1) | AU2005277638A1 (https=) |
| BR (1) | BRPI0514438A (https=) |
| CA (1) | CA2577100A1 (https=) |
| IL (1) | IL181160A0 (https=) |
| MA (1) | MA28814B1 (https=) |
| MX (1) | MX2007001958A (https=) |
| NO (1) | NO20071161L (https=) |
| PE (1) | PE20060646A1 (https=) |
| RU (1) | RU2350604C2 (https=) |
| TW (1) | TW200619217A (https=) |
| WO (1) | WO2006023400A2 (https=) |
| ZA (1) | ZA200701282B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7728026B2 (en) | 2005-04-11 | 2010-06-01 | Abbott Laboratories, Inc. | 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors |
| PT1942108E (pt) | 2005-10-28 | 2013-10-24 | Ono Pharmaceutical Co | Composto com um grupo básico e a sua utilização |
| WO2007058322A1 (ja) | 2005-11-18 | 2007-05-24 | Ono Pharmaceutical Co., Ltd. | 塩基性基を含有する化合物およびその用途 |
| EP2042503B1 (en) | 2006-05-16 | 2013-01-30 | Ono Pharmaceutical Co., Ltd. | Compound having acidic group which may be protected, and use thereof |
| WO2008016006A1 (fr) | 2006-07-31 | 2008-02-07 | Ono Pharmaceutical Co., Ltd. | Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation |
| GB0702695D0 (en) * | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Production of vectors |
| AR066162A1 (es) * | 2007-07-31 | 2009-07-29 | Bayer Cropscience Sa | Derivados fungicidas de n- cicloalquil -n- carboxamida- biciclica |
| US20100222381A1 (en) | 2009-02-27 | 2010-09-02 | Hariprasad Vankayalapati | Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors |
| JP5541454B2 (ja) * | 2009-09-16 | 2014-07-09 | Ｊｓｒ株式会社 | 液晶配向剤および液晶表示素子 |
| JP5712524B2 (ja) * | 2009-10-28 | 2015-05-07 | Jsr株式会社 | 液晶配向剤および液晶表示素子 |
| JP5719028B2 (ja) | 2010-10-06 | 2015-05-13 | グラクソスミスクライン エルエルシー | Ｐｉ３キナーゼ阻害剤としてのベンズイミダゾール誘導体 |
| CN102675305B (zh) * | 2011-03-08 | 2014-11-12 | 中国科学院上海药物研究所 | 一类咪唑并吡啶类化合物及其制备方法和用途 |
| CN103570683B (zh) * | 2012-07-30 | 2018-04-17 | 中国科学院上海药物研究所 | 多取代胺类化合物及其制备方法和用途 |
| CN109069426B (zh) | 2015-12-14 | 2021-10-29 | X4 制药有限公司 | 治疗癌症的方法 |
| WO2017106332A1 (en) | 2015-12-14 | 2017-06-22 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| PL3393468T3 (pl) | 2015-12-22 | 2023-01-23 | X4 Pharmaceuticals, Inc. | Metody leczenia niedoboru odporności |
| US11337969B2 (en) | 2016-04-08 | 2022-05-24 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| CN109640988A (zh) | 2016-06-21 | 2019-04-16 | X4 制药有限公司 | Cxcr4抑制剂及其用途 |
| WO2017223243A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
| ES2870920T3 (es) | 2016-06-21 | 2021-10-28 | X4 Pharmaceuticals Inc | Inhibidores de CXCR4 y usos de los mismos |
| EP3585387A4 (en) | 2017-02-21 | 2020-08-12 | Emory University | CHEMIOKIN CXCR4 RECEIVER MODULATORS AND THEIR USES |
| JP7282786B2 (ja) * | 2017-09-25 | 2023-05-29 | シージーンテック （スーチョウ， チャイナ） カンパニー リミテッド | Ｃｘｃｒ４阻害剤としてのヘテロアリール化合物、それを用いた組成物及び方法 |
| KR102678977B1 (ko) * | 2017-09-25 | 2024-06-28 | 씨젠테크 (쑤저우, 차이나) 컴퍼니 리미티드 | Cxcr4 저해제로서 헤테로아릴 화합물, 그 조성물 및 이용 방법 |
| US11649235B2 (en) | 2018-03-19 | 2023-05-16 | Emory University | Pan-tropic entry inhibitors |
| US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
| CA3171250A1 (en) | 2020-03-10 | 2021-09-16 | E. Lynne KELLEY | Methods for treating neutropenia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004512336A (ja) * | 2000-09-15 | 2004-04-22 | アノーメッド インコーポレイティド | ケモカインレセプター結合複素環式化合物 |
| PT1317451E (pt) * | 2000-09-15 | 2006-12-29 | Anormed Inc | Compostos heterocíclicos que se ligam a receptores de quimioquinas |
| US6835731B2 (en) * | 2000-09-15 | 2004-12-28 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| CA2419224A1 (en) * | 2000-09-15 | 2002-03-21 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
| CA2467718C (en) * | 2001-12-21 | 2011-04-26 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| CN1930127B (zh) * | 2004-03-15 | 2012-11-21 | 阿诺麦德股份有限公司 | 用于合成cxcr4拮抗剂的方法 |
-
2005
- 2005-08-12 CA CA002577100A patent/CA2577100A1/en not_active Abandoned
- 2005-08-12 CN CNA2005800351651A patent/CN101039672A/zh active Pending
- 2005-08-12 MX MX2007001958A patent/MX2007001958A/es not_active Application Discontinuation
- 2005-08-12 WO PCT/US2005/028811 patent/WO2006023400A2/en not_active Ceased
- 2005-08-12 EP EP05786708A patent/EP1789045A2/en not_active Withdrawn
- 2005-08-12 RU RU2007105823/04A patent/RU2350604C2/ru not_active IP Right Cessation
- 2005-08-12 AR ARP050103418A patent/AR050522A1/es not_active Application Discontinuation
- 2005-08-12 KR KR1020077005000A patent/KR20070042568A/ko not_active Withdrawn
- 2005-08-12 AU AU2005277638A patent/AU2005277638A1/en not_active Abandoned
- 2005-08-12 TW TW094127423A patent/TW200619217A/zh unknown
- 2005-08-12 JP JP2007527895A patent/JP2008510006A/ja active Pending
- 2005-08-12 US US11/573,729 patent/US20080045537A1/en not_active Abandoned
- 2005-08-12 BR BRPI0514438-8A patent/BRPI0514438A/pt not_active IP Right Cessation
- 2005-08-12 PE PE2005000940A patent/PE20060646A1/es not_active Application Discontinuation
-
2007
- 2007-02-05 IL IL181160A patent/IL181160A0/en unknown
- 2007-02-13 ZA ZA200701282A patent/ZA200701282B/xx unknown
- 2007-02-21 MA MA29700A patent/MA28814B1/fr unknown
- 2007-03-01 NO NO20071161A patent/NO20071161L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008510006A5 (https=) | ||
| JP2008511668A5 (https=) | ||
| US11905283B2 (en) | Compounds and compositions for inhibiting the activity of SHP2 | |
| EP3788050B1 (en) | C26-linked rapamycin analogs as mtor inhibitors | |
| RU2351592C2 (ru) | Производные тетрагидрохинолина и фармацевтическая композиция на их основе для лечения и профилактики вич-инфекции | |
| US11529347B2 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
| KR101970837B1 (ko) | 항바이러스제로서의 피라졸로[1,5-ａ]피리미딘 | |
| JP2008511669A5 (https=) | ||
| RU2486188C9 (ru) | СОЕДИНЕНИЯ ИМИДАЗО[1,2-B]ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО[1,2-b]ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С ИНГИБИРОВАНИЕМ ГАМКА РЕЦЕПТОРОВ | |
| US10786492B2 (en) | Formylated N-heterocyclic derivatives as FGFR4 inhibitors | |
| CA3085346A1 (en) | Amide substituted indole compounds useful as tlr inhibitors | |
| JP2008516973A5 (https=) | ||
| CN108366992A (zh) | 蛋白水解靶向嵌合体化合物及其制备和应用方法 | |
| CN106413716A (zh) | 通过jak和pi3k抑制剂组合治疗b细胞恶性肿瘤 | |
| CN107849024A (zh) | 具有作为吲哚胺2,3‑二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物 | |
| RU2010116759A (ru) | Пиримидиновые производные, используемые в качестве ингибиторов протеинкиназы | |
| JP2024513227A (ja) | Ｎｅｋ７阻害剤 | |
| JP7712942B2 (ja) | トール様受容体７（ＴＬＲ７）アゴニストとしての１Ｈ－ピラゾロ［４，３－ｄ］ピリミジン化合物 | |
| JPWO2022128584A5 (https=) | ||
| WO2010053127A1 (ja) | α1GABAA受容体またはα5GABAA受容体の調整剤 | |
| JP2008533082A5 (https=) | ||
| RU2399621C2 (ru) | ЗАМЕЩЕННЫЕ 2-АЛКИЛАМИНО-3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ, АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
| TW202321248A (zh) | 酪胺酸激酶抑制劑 | |
| JP2025524064A (ja) | Ａｋｒ１ｃ３依存性ｋａｒｓ阻害剤の結晶形態 | |
| JP2026506696A (ja) | Ｒｅｔキナーゼの分解剤としてのイソインドリノングルタルイミドおよびフェニルグルタルイミドのアナログ |